{"id":11849,"date":"2023-05-16T11:53:58","date_gmt":"2023-05-16T09:53:58","guid":{"rendered":"https:\/\/ggba.swiss\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/"},"modified":"2023-07-04T13:44:19","modified_gmt":"2023-07-04T11:44:19","slug":"newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/","title":{"rendered":"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions"},"content":{"rendered":"\n<p>La plateforme bas\u00e9e sur l&rsquo;ADN de <a href=\"https:\/\/www.newbiologix.com\/\" target=\"_blank\" rel=\"noopener\">NewBiologix<\/a> cible les principaux d\u00e9fis de fabrication entourant les vecteurs de virus ad\u00e9no-associ\u00e9s recombinants (rAAV), couramment utilis\u00e9s dans les produits de th\u00e9rapie m\u00e9dicinale avanc\u00e9e (ATMPs). NewBiologix se concentre actuellement sur les vecteurs rAAV car ils sont le vecteur privil\u00e9gi\u00e9 pour les th\u00e9rapies g\u00e9niques.<\/p>\n<p>\u00ab\u00a0Notre mission est d&rsquo;aider les entreprises biopharmaceutiques \u00e0 traiter certaines des maladies les plus d\u00e9vastatrices en leur fournissant des technologies et des solutions innovantes pour augmenter la production et l&rsquo;efficacit\u00e9 des vecteurs viraux, rapidement et de mani\u00e8re plus rentable\u00a0\u00bb, a d\u00e9clar\u00e9 le co-fondateur et CEO, Igor Fisch.<\/p>\n<p>Le tour de financement, dirig\u00e9 par Recipharm A\/S, une organisation de d\u00e9veloppement et de fabrication de contrats pharmaceutiques mondialement reconnue, permettra \u00e0 NewBiologix de commencer les tests b\u00eata des prototypes de lign\u00e9es cellulaires d&rsquo;ici 2024. Ils pr\u00e9voient de rendre les lign\u00e9es cellulaires de production virale commercialement disponibles d&rsquo;ici 2026.<\/p>\n<p>La start-up est bas\u00e9e au <a href=\"https:\/\/www.biopole.ch\/\" target=\"_blank\" rel=\"noopener\">Biop\u00f4le<\/a> \u00e0 Epalinges (canton de Vaud), une communaut\u00e9 des sciences de la vie qui encourage la collaboration, l&rsquo;innovation et le transfert de connaissances. Le Biop\u00f4le offre des infrastructures de pointe et une large gamme de services professionnels \u00e0 ses membres, offrant un environnement id\u00e9al pour des entreprises comme NewBiologix. L&rsquo;inauguration r\u00e9cente des nouvelles installations de NewBiologix marque un autre chapitre passionnant dans l&rsquo;histoire \u00e0 succ\u00e8s du Biop\u00f4le.<\/p>\n<h4>Biop\u00f4le: un hub pour l&rsquo;innovation<\/h4>\n<p>Le Biop\u00f4le est une communaut\u00e9 dynamique des sciences de la vie, proposant des laboratoires et des espaces de bureau de pointe \u00e0 plus de 100 entreprises et institutions, dans un environnement qui soutient l&rsquo;innovation et la collaboration. NewBiologix rejoint le campus avec 1\u2019800 m\u00e8tres carr\u00e9s d\u00e9di\u00e9s \u00e0 des espaces administratifs et des laboratoires de pointe.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"\/\/www.youtube.com\/embed\/9dfaWFUSaxE\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h4>La Suisse occidentale : un lieu privil\u00e9gi\u00e9 pour les entreprises biotechnologiques<\/h4>\n<p>La Suisse occidentale devient de plus en plus attractive pour les start-ups biotechnologiques comme NewBiologix. Avec des universit\u00e9s et des instituts de recherche de classe mondiale, un environnement r\u00e9glementaire favorable et une solide r\u00e9putation en mati\u00e8re d&rsquo;innovation, la r\u00e9gion offre un terreau id\u00e9al pour des perc\u00e9es en biotechnologie.<\/p>\n<p>De plus, l&rsquo;engagement de la r\u00e9gion \u00e0 favoriser les r\u00e9seaux de collaboration entre le monde acad\u00e9mique, l&rsquo;industrie et le gouvernement a abouti \u00e0 un \u00e9cosyst\u00e8me dynamique propice \u00e0 la croissance et au succ\u00e8s des entreprises. Ce soutien, combin\u00e9 \u00e0 une richesse de talents et de ressources, fait de la Suisse occidentale <a href=\"https:\/\/investinswitzerland.com\/biomanufacturing-2\/?lang=fr\" target=\"_blank\" rel=\"noopener\">un v\u00e9ritable foyer d&rsquo;innovation en biotechnologie<\/a>, comme en t\u00e9moigne le nouveau succ\u00e8s de NewBiologix.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NewBiologix, une start-up de biotechnologie fond\u00e9e par les v\u00e9t\u00e9rans de l&rsquo;industrie Igor Fisch et Nicolas Mermod, a annonc\u00e9 une lev\u00e9e de fonds de s\u00e9rie A de USD 50 millions.<\/p>\n","protected":false},"author":3,"featured_media":11850,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1022,1041,1045,1082],"class_list":["post-11849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr","tag-financing-fr","tag-gene-therapy-fr","tag-technology-park-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"NewBiologix, une start-up de biotechnologie fond\u00e9e par les v\u00e9t\u00e9rans de l&#039;industrie Igor Fisch et Nicolas Mermod, a annonc\u00e9 une lev\u00e9e de fonds de s\u00e9rie A de USD 50 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-16T09:53:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions\",\"datePublished\":\"2023-05-16T09:53:58+00:00\",\"dateModified\":\"2023-07-04T11:44:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\"},\"wordCount\":461,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg\",\"keywords\":[\"Biotech\",\"Financing\",\"Gene Therapy\",\"Technology Park\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\",\"name\":\"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg\",\"datePublished\":\"2023-05-16T09:53:58+00:00\",\"dateModified\":\"2023-07-04T11:44:19+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions - Greater Geneva Bern area","og_description":"NewBiologix, une start-up de biotechnologie fond\u00e9e par les v\u00e9t\u00e9rans de l'industrie Igor Fisch et Nicolas Mermod, a annonc\u00e9 une lev\u00e9e de fonds de s\u00e9rie A de USD 50 millions.","og_url":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-05-16T09:53:58+00:00","article_modified_time":"2023-07-04T11:44:19+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions","datePublished":"2023-05-16T09:53:58+00:00","dateModified":"2023-07-04T11:44:19+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/"},"wordCount":461,"image":{"@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg","keywords":["Biotech","Financing","Gene Therapy","Technology Park"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/","url":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/","name":"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg","datePublished":"2023-05-16T09:53:58+00:00","dateModified":"2023-07-04T11:44:19+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NewBiologix-630x380-1-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/newbiologix-pionnier-des-therapies-geniques-revolutionnaires-leve-usd-50-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"NewBiologix, pionnier des th\u00e9rapies g\u00e9niques r\u00e9volutionnaires, l\u00e8ve USD 50 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11849"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11849\/revisions"}],"predecessor-version":[{"id":18373,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11849\/revisions\/18373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11850"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}